Péptidos

A synthetic peptide for use as a blocking control in assays to test for specificity of TMC2 antibody, catalog no. 70R-6319

Custom research peptide; min purity 95%.

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF619 antibody, catalog no. 70R-8157

A synthetic peptide for use as a blocking control in assays to test for specificity of IDH1 antibody, catalog no. 70R-2495

A synthetic peptide for use as a blocking control in assays to test for specificity of FAM90A1 antibody, catalog no. 70R-4363

Custom research peptide; min purity 95%.

A synthetic peptide for use as a blocking control in assays to test for specificity of FDXR antibody, catalog no. 70R-2532

Custom research peptide; min purity 95%.

A synthetic peptide for use as a blocking control in assays to test for specificity of POLR1E antibody, catalog no. 70R-3384

A synthetic peptide for use as a blocking control in assays to test for specificity of MAP1LC3A antibody, catalog no. 70R-2895

A synthetic peptide for use as a blocking control in assays to test for specificity of CXCL14 antibody, catalog no. 20R-1308

CBZ-N-Amido-dPEG®4-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. CBZ-N-Amido-dPEG®4-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNMB4 antibody, catalog no. 70R-5108

A synthetic peptide for use as a blocking control in assays to test for specificity of EPS8L1 antibody, catalog no. 70R-1259

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF440 antibody, catalog no. 70R-8127

FRET-25Asp is a peptide that can be used in research as an activator, antibody, and inhibitor. It is used as a tool to study protein interactions with the cell membrane and ion channels. FRET-25Asp has also been shown to inhibit the activity of some receptors and ligands.

A synthetic peptide for use as a blocking control in assays to test for specificity of CTDSP2 antibody, catalog no. 70R-3879

A synthetic peptide for use as a blocking control in assays to test for specificity of FANCE antibody, catalog no. 70R-2296

A synthetic peptide for use as a blocking control in assays to test for specificity of TLE4 antibody, catalog no. 70R-7916

A synthetic peptide for use as a blocking control in assays to test for specificity of ZFP90 antibody, catalog no. 70R-7874

DBCO-dPEG®12-TFP Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. DBCO-dPEG®12-TFP Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of TRDMT1 antibody, catalog no. 70R-2240

A synthetic peptide for use as a blocking control in assays to test for specificity of MTPN antibody, catalog no. 70R-2590

A synthetic peptide for use as a blocking control in assays to test for specificity of DIRAS1 antibody, catalog no. 70R-5821

A synthetic peptide for use as a blocking control in assays to test for specificity of PPP2R5E antibody, catalog no. 70R-9425

A synthetic peptide for use as a blocking control in assays to test for specificity of DCDC2 antibody, catalog no. 70R-4501

APETx2 is a peptide that belongs to the inhibitor class of protein interactions. It has been shown to inhibit the activation of beta-adrenergic receptors by preventing the binding of the ligand, which is a catecholamine. APETx2 also has been shown to be an activator for muscarinic acetylcholine receptors. This peptide is a high purity research tool that can be used as an antibody conjugate in immunohistochemical and immunoprecipitation assays.

A synthetic peptide for use as a blocking control in assays to test for specificity of C19orf47 antibody, catalog no. 70R-3346

A synthetic peptide for use as a blocking control in assays to test for specificity of ASPH antibody, catalog no. 70R-7074

A synthetic peptide for use as a blocking control in assays to test for specificity of C10orf96 antibody, catalog no. 70R-3327

A synthetic peptide for use as a blocking control in assays to test for specificity of UBE2C antibody, catalog no. 70R-5588

A synthetic peptide for use as a blocking control in assays to test for specificity of ACAT1 antibody, catalog no. 70R-2469

A synthetic peptide for use as a blocking control in assays to test for specificity of KHDRBS3 antibody, catalog no. 70R-4610

SARS Coronavirus is an enveloped virus containing 3 outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein takes part in the virus infection cycle and is the primary target of neutralizing antibodies. The recombinant SARS Spike containing a total of 220 amino acids (306-515) and having a calculated M.W. of 24.8 kDa.SARS Spike  is fused to a 6 amino acid His-tag at C-terminus, and is purified by proprietary chromatographic techniques. Of a HEK293 source the formulation of the SARS Spike (306-515) solution (0.5mg/ml) contains Phosphate-Buffered Saline (pH 7.4) and 10% Glycerol.
One-Letter Formula: DGSMRVVPSG DVVRFPNITN LCPFGEVFNA TKFPSVYAWE RKKISNCVAD YSVLYNSTFF STFKCYGVSA TKLNDLCFSN VYADSFVVKG DDVRQIAPGQ TGVIADYNYK LPDDFMGCVL AWNTRNIDAT STGNYNYKYR YLRHGKLRPF ERDISNVPFS PDGKPCTPPA LNCYWPLNDY GFYTTTGIGY QPYRVVVLSF ELLNAPATVC GPKLHHHHHH

PC Biotin Alkyne probes eliminate a major limitation of the streptavidin-biotin affinity purification. This reagent contains a biotin moiety linked to an azide moiety through a spacer arm containing a photocleavable linker. Captured biomolecules can be efficiently released under mild, reagent-free conditions (irradiation with near-UV, low intensity lamp) and the small molecular fragment (55.07 Da) left on the labelled protein following cleavage. These features make the photocleavable probe especially attractive for use in biomolecular labelling and proteomic studies.

A synthetic peptide for use as a blocking control in assays to test for specificity of CYP3A7 antibody, catalog no. 70R-1867

A synthetic peptide for use as a blocking control in assays to test for specificity of KLF14 antibody, catalog no. 70R-8111

MAL-dPEG®4-Lys(TFA-)-NH-m-dPEG®24 is a peptide containing polyethylene glycol (PEG) as spacer to alter their pharmacokinetic properties and pharmodynamics.

t-boc-N-Amido-dPEG®12-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. t-boc-N-Amido-dPEG®12-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of AP3S1 antibody, catalog no. 70R-9130

Beta-Sheet Breaker Peptide iAß5 is a peptide that interacts with amyloid beta proteins to disrupt the formation of beta sheets. It has been shown to inhibit the aggregation of amyloid beta proteins into oligomers and fibrils, and disrupts the self-assembly of amyloid beta protein into various conformations. Beta-Sheet Breaker Peptide iAß5 is a ligand for both receptor and activator binding sites on amyloid beta proteins, inhibiting the interaction of these sites. This inhibits the activation of downstream signalling pathways associated with Alzheimer's disease.

A synthetic peptide for use as a blocking control in assays to test for specificity of NOL5A antibody, catalog no. 70R-4804

A synthetic peptide for use as a blocking control in assays to test for specificity of Apbb1 antibody, catalog no. 70R-9328

A synthetic peptide for use as a blocking control in assays to test for specificity of PPIE antibody, catalog no. 70R-1434

A synthetic peptide for use as a blocking control in assays to test for specificity of ARL17 antibody, catalog no. 70R-3805

A synthetic peptide for use as a blocking control in assays to test for specificity of CX36 antibody, catalog no. 70R-1689

Anti-TNF-alpha (rat) serum is a protein that blocks the effects of tumor necrosis factor-alpha. This protein has been shown to regulate the immune system and inhibit inflammation. Anti-TNF-alpha (rat) serum is a high quality, purified protein for use as a research tool in cell biology or other life science applications. The product is supplied at a concentration of 1 mg/ml in phosphate buffered saline with 0.02% sodium azide and is suitable for use in mammalian experiments.

MAGE-A1 protein:
MAGE-A1 (278-286) is an epitope of Melanoma Antigen Gene A1 expressed by tumors of different histological types such as on the surface of breast carcinoma cell and is a Cancer/Testis Antigens (CTA). MAGE-A1 is a tumor antigen expressed in 40% of melanoma and contains epitope for binding HLA-A*02:01 molecules and that are recognized by cytotoxic T cells.
Applications of MAGE-A1 (278-286):
MAGE-A1 (278-286) is used to stimulate specific cytotoxic T cells in PBMCs and to analyze by ELISPOT peptide epitope specificity and cytokine production like IFN-γ. Immunogenicity of MAGE-A1 (278-286) raised the possibility of developing anticancer immunotherapies or vaccinations. MAGE-A1 is also expressed in lung adenocarcinoma and studies suggest that MAGE-A1 may serve to develop Chimeric Antigen Receptor (CAR) T cell therapy using lentiviral vector and show an encouraging tumor-inhibitory efficacy.

Huwentoxin XVI is a synthetic molecule that inhibits the transmission of pain signals. It does this by inhibiting the release of neurotransmitters from dorsal root ganglia cells in the spinal cord. Huwentoxin XVI has been shown to inhibit the cancer-associated inflammatory response, which may be due to its ability to inhibit chronic pain. In addition, Huwentoxin XVI has been shown to have an inhibitory effect on adipose tissue and is thought to be a potential treatment for obesity-associated chronic pain. Huwentoxin XVI also blocks A-type potassium channels, which are responsible for neuronal transmission and are found in neurons and glial cells in the dorsal root ganglia. This inhibition can lead to neuropathic pain or chronic pain caused by nerve damage.